[Webinar] Manufacturing concepts for antibody-drug conjugates | Webinar
The antibody-drug conjugate (ADC) market is witnessing rapid growth due to increased demand for targeted cancer therapies and improved conjugation technologies. Watch our STAT webinar to gain insights on the latest ADC advancements and discover the critical role CDMOs play in ensuring safe and efficient manufacturing processes. Check out the full video: [Link] #SamsungBiologics #ADCs #cdmo
▶︎
The Evolution of Antibody-Drug Conjugates in Oncology: Have we found our “Magic Bullet”? | Dr. Krop
▶︎
Development and Delivery of Pharmaceutical Products (CMC) - MaRS Best Practices
▶︎
Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA
▶︎
Anatomy of a Lyophilization Process Considerations for a Successful Tech Transfer
▶︎
CNTR Research Methodology Webinar #2
▶︎
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
▶︎
WEBINAR: Overview of CMC Biotechnology Webinar - Dr Nadine Ritter
▶︎
Navigating Cancer Immunotherapy: Exploring the World of mRNA Vaccines
▶︎
Antibody–Drug Conjugates for Solid Tumors: Progress, Possibilities, and Implications for Care
▶︎
Antibody Drug Conjugates: Safety and Efficacy (2025)
▶︎
Antibody-drug Conjugates in the Clinic:
▶︎
Cancer: mitochondria and metabolism - a discussion with Thomas Seyfried and his group
▶︎
2026 ASMS Thermo Scientific Breakfast Workshop: Reducing Variability in Bile Acids with MoveKit BA
▶︎
“Physician Billing (de)Coding” - Dr. Cecilia Leggett, 2026-06-10 Grand Rounds
▶︎
Comprehensive Analytical Strategies for ADC and mAb Control
▶︎
AFSA Webinar: Introduction to the AFSA global regulatory transformation strategy
▶︎
The ABC's of Formulation Development for Parenteral Drug Product Manufacturing
▶︎
Critical Care Cardiology: Navigating Training & Fellowship Applications
▶︎
The ABCs of ADC characterisation
▶︎